Medtronic plc (MDT) officer has 439 shares withheld to cover tax obligations

Rhea-AI Filing Summary

Medtronic plc reported a routine insider transaction by one of its executives. The officer, listed as EVP & President Neuroscience, had 439 ordinary shares withheld on 12/15/2025 to pay taxes due when previously granted restricted stock units vested, at a price of $99.87 per share.

After this tax-withholding transaction, the reporting person directly owns 54,749 Medtronic ordinary shares. This total includes 251 shares that were acquired through dividend reinvestment since the prior report.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wall Brett A.

(Last) (First) (Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MN 55432

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Pres Neuroscience

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	12/15/2025		F		439(1)	D	$99.87	54,749(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility.

2. Includes 251 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Medtronic plc (MDT) report in this filing?

A Medtronic plc executive reported a routine insider transaction where 439 ordinary shares were withheld on 12/15/2025 to cover taxes upon the vesting of previously granted restricted stock units at $99.87 per share.

Is the Medtronic plc (MDT) insider transaction an open-market sale?

No. The filing states that the 439 shares represent shares withheld for payment of taxes upon the vesting of restricted stock units, rather than an open-market discretionary sale.

How many Medtronic plc (MDT) shares does the reporting person own after the transaction?

Following the reported tax-withholding transaction, the reporting person directly owns 54,749 Medtronic ordinary shares.

What is the role of the Medtronic plc (MDT) insider involved in this transaction?

The reporting person is identified as an officer of Medtronic plc, with the title EVP & Pres Neuroscience.

What do the additional 251 Medtronic plc (MDT) shares mentioned in the filing represent?

The share count after the transaction includes 251 shares that were acquired through dividend reinvestment since the last report filed by the reporting person.

What transaction code is used for the Medtronic plc (MDT) insider transaction and what does it indicate?

The transaction is reported with code "F", which in this context corresponds to shares withheld for payment of taxes upon the vesting of restricted stock units.